Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R, Giagounidis A, Hildebrandt B, Bernasconi P, Knipp S, Strupp C, Lazzarino M, Aul C, Cazzola M

J Clin Oncol. 2007 Aug 10;25(23):3503-10

Intensive chemotherapy is not recommended for patients aged &gt;60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes.

Knipp S, Hildebrand B, Kündgen A, Giagounidis A, Kobbe G, Haas R, Aul C, Gattermann N, Germing U

Cancer. 2007 Jul 15;110(2):345-52

Education et formation

ISFM en hématologie: 2007
ISFM en médecine interne: 2007
Diplôme de médecine: 2001

Institutions de formation & expériences précédentes

Faculté de médecine, Heinrich-Heine-Universität (Düsseldorf)

HUG
Universitätsklinikum Düsserdorf
Spital Tiefenau (Berne)
Regionales Spitalzentrum Aare-Kiesental (Münsingen)

Langues parlées

Français, Allemand, Anglais

Département d'oncologie UNIL-CHUV
Rue du Bugnon 46
CH-1011 Lausanne, Vaud, Suisse
+41 21 314 0155

Impressum
Informations juridiques
Plan du site
Formulaire de contact

Dernière mise à jour le 10/06/2024 à 17:43

Pre Sabine Blum

Études cliniques sélectionnées en cours

Ten-year single-centre experience in fertility preservation of 459 patients suffering from acute leukaemia.

Immunotherapy in adult acute leukemia.

Innovative strategies for adverse karyotype acute myeloid leukemia.

Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.

Intensive chemotherapy is not recommended for patients aged &amp;gt;60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes.

Langues parlées

Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes.